Company intelligence / Profile preview

Avlar BioVentures

La Jolla, California, United States

Ownership: Private
Employees: ~110
Development stage: Other

Overview

Avalon BioVentures is a venture capital firm specializing in seed/early-stage biotech investments. It operates an ABV Accelerator program to foster new ventures and has a strong track record of successful portfolio company exits, including significant acquisitions by major pharmaceutical companies.

Industry: Investors

Partnerships

GlaxoSmithKline (GSK)GenentechFibrogenCullinan Therapeutics

Beyond the preview

Go deeper on Avlar BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avlar BioVentures.

Explore the full profile